Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inpharamo is a Mexico-based healthcare company focused on introducing and commercializing foreign medical devices, digital health products, and clinical research technologies in the Mexican market. Publicly available information indicates it operates as a subsidiary or affiliated vehicle of Spain-based Semicrol and provides regulatory, sales, marketing, logistics, and market-entry support for international health technology companies. Reported partnerships include commercialization support for AliveCor's KardiaMobile in Mexico, distribution of NuvoAir's respiratory platform, and collaboration with Clinerion to expand clinical trial patient-identification capabilities in Mexican hospitals and research institutes. The company appears to be commercially oriented rather than a therapeutic drug developer, with activity centered on connected medical devices, digital diagnostics, and research-enablement solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inpharamo.